Q&A with Mickey Kertesz, Chief Executive Officer, Karius
Q: Tell us a little bit about Karius – what problem(s)/need(s) are you trying to address and what technology is behind it to achieve this?
read moreJoin PMWC 2018 Michigan This June to Learn More about How the Modulation of the Epigenome Increases the Risk for Type 2 Diabetes
Dr. Michael Boehnke (University of Michigan) – who pioneered large-scale studies identifying genetic risk in diabetes and bipolar disorder – shared with us some recent insights about recent advances in exome and genome sequencing and their applications to better understand disease biology and etiology of psychiatric disorders
read moreAI and Machine Learning in Healthcare – Not Just Hype Anymore
AI and machine learning has gotten a lot of attention over the last year, as it appears to be poised to become one of the biggest game changer in many industries, including the healthcare sector.
read moreQ&A with Eric Lefkofsky, CEO of Tempus and Co-founder of Groupon
“Treating a cancer patient without the benefit of modern software is the same as driving at night without headlights”
read morePMWC Michigan – Big Data in Action: Data-Driven Insights in the Clinic
We are excited to launch the first Precision Medicine World Conference (PMWC) at the University of Michigan June 6-7, 2018.
read moreQ&A with Susan A. Murphy, Harvard University
Q: Your lab develops experimental trial designs and data analysis methods for increasing the usefulness of mobile health interventions. Can you please give examples how these trials are being used in the areas of substance abuse, physical activity, or helping people quit smoking?
read moreQ&A with Dr. Dara Richardson-Heron, Chief Engagement Officer, All of Us
Q: Your reputation for passion about engaging and empowering people precedes you. Can you please describe your role at the All of Us Research Program?
read moreLate breaking: Dawn Barry leaves Illumina to lead LunaDNA -Blockchain Disrupting Healthcare Industry
“Every individual holds a valuable piece of the puzzle to understand disease and health, and researchers are all in need of more data. Discovery is hindered by putting the majority of data into small silos. Breaking down data silos and bringing individuals together will more quickly aggregate enough samples to rise above the complexity of genomics and identify disease candidates.” – Dawn Barry, President and Co-Founder, Luna DNA
read moreInterview Dawn Barry the new President and Co-founder of LunaDNA
Q: In a sentence, what is Luna DNA going to do?
read moreJPM18: Edico Genome, Illumina, Invitae, Regeneron, Thermo Fisher Scientific,… and the list goes on
It’s been an announcement-packed JPMorgan Healthcare Conference in San Francisco this week!
read more
